First-line Nivolumab Plus Ipilimumab vs Sunitinib for Metastatic Renal Cell Carcinoma

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

American Medical Association (AMA)

Online

2019-02-22

DOI

10.1001/jamaoncol.2018.7086

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started